2.0000
+0.0300
+(1.52%)
At close: January 17 at 4:00:00 PM EST
2.0000
0.00
(0.00%)
After hours: January 17 at 4:00:11 PM EST
Key Executives
Key Executives Information Not Available
Rein Therapeutics Inc.
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Rein Therapeutics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 14, 2025 at 10:59 AM UTC - April 18, 2025 at 12:00 PM UTC
Rein Therapeutics Inc. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
ACTU Actuate Therapeutics, Inc. Common stock
8.62
+0.82%
RNXT RenovoRx, Inc.
1.5000
+6.38%
CUE Cue Biopharma, Inc.
1.3100
+2.34%
FRTX Fresh Tracks Therapeutics, Inc.
0.6600
0.00%
CYCN Cyclerion Therapeutics, Inc.
2.9900
+2.75%
INAB IN8bio, Inc.
0.2962
-0.13%
LTRN Lantern Pharma Inc.
3.6900
+2.50%
QNCX Quince Therapeutics, Inc.
1.6600
-3.49%
CGTX Cognition Therapeutics, Inc.
0.6818
-1.80%
ABEO Abeona Therapeutics Inc.
5.22
-0.38%